发明名称 Compounds as histamine H3 receptor ligands
摘要 The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them.;;The present invention also relates to a process for the preparation of above compounds of formula (I), and their pharmaceutically acceptable salts.;The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine H3 receptors.
申请公布号 US9079888(B2) 申请公布日期 2015.07.14
申请号 US201114000362 申请日期 2011.06.07
申请人 Suven Life Sciences Limited 发明人 Nirogi Ramakrishna;Shinde Anil Karbhari;Kambhampati Ramasastri;Deshpande Amol Dinakar;Dwarampudi Adi Reddy;Gangadasari Narasimhareddy;Saraf Sangram Keshari;Kandikere Vishwottam Nagaraj;Jayarajan Pradeep;Ahmad Ishtiyaque;Mulla Mohmadsadik Abdulhamid;Jasti Venkateswarlu
分类号 C07D401/12;C07D405/12;C07D413/12;C07D401/14;C07D211/46 主分类号 C07D401/12
代理机构 IpHorgan Ltd. 代理人 IpHorgan Ltd.
主权项 1. A compound of the general formula (I):wherein, at each occurrence, R1 is independently selected from hydrogen, hydroxy, hydroxyalkyl, halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, cyano or —C(O)—NH2; L is alkyl or X is C, O or N—R2; Y is C or N; A is —C(O)— or —CH2; R2 is hydrogen, alkyl, —C(O)-alkyl or —S(O)2-alkyl; “r” is 0 or 1; “p” is an integer ranging from 0 to 3;or a pharmaceutically acceptable salt thereof.
地址 Hyderabad IN